CASTLE BIOSCIENCES, INC. Depreciation
CASTLE BIOSCIENCES, INC. (CSTL) reported Depreciation of $1.82 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. depreciation for the quarter ending 2026-06-30 was $1.82M, a 25.19% increase year-over-year.
- CASTLE BIOSCIENCES, INC. depreciation for the quarter ending 2026-03-31 was $1.70M, a 18.35% increase year-over-year.
- CASTLE BIOSCIENCES, INC. depreciation for the quarter ending 2025-12-31 was $1.50M, a 5.11% increase year-over-year.
- CASTLE BIOSCIENCES, INC. depreciation for the quarter ending 2025-09-30 was $1.54M, a 21.36% increase year-over-year.
- CASTLE BIOSCIENCES, INC. depreciation for fiscal 2025 was $5.93M, a 21.30% increase from fiscal 2024.
- CASTLE BIOSCIENCES, INC. depreciation for fiscal 2024 was $4.89M, a 47.45% increase from fiscal 2023.
- CASTLE BIOSCIENCES, INC. depreciation for fiscal 2023 was $3.32M, a 45.61% increase from fiscal 2022.
- CASTLE BIOSCIENCES, INC. depreciation for fiscal 2022 was $2.28M, a 57.32% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.82M 10-Q · filed 2026-07-30 | $3.52M 10-Q · filed 2026-07-30 | $5.02M derived: sum of 3 quarters · filed 2026-07-30 | $6.56M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | $1.70M 10-Q · filed 2026-05-06 | $3.20M derived: sum of 2 quarters · filed 2026-05-06 | $4.74M derived: sum of 3 quarters · filed 2026-05-06 | $6.20M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.04M derived: sum of 2 quarters · filed 2026-02-26 | $4.49M derived: sum of 3 quarters · filed 2026-07-30 | $5.93M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $1.54M 10-Q · filed 2025-11-03 | $2.99M derived: sum of 2 quarters · filed 2026-07-30 | $4.43M 10-Q · filed 2025-11-03 | $5.86M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | $1.45M 10-Q · filed 2026-07-30 | $2.89M 10-Q · filed 2026-07-30 | $4.32M derived: sum of 3 quarters · filed 2026-07-30 | $5.59M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-03-31 | $1.44M 10-Q · filed 2026-05-06 | $2.87M derived: sum of 2 quarters · filed 2026-05-06 | $4.14M derived: sum of 3 quarters · filed 2026-05-06 | $5.24M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.70M derived: sum of 2 quarters · filed 2026-02-26 | $3.80M derived: sum of 3 quarters · filed 2026-02-26 | $4.89M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $1.27M 10-Q · filed 2025-11-03 | $2.37M derived: sum of 2 quarters · filed 2025-11-03 | $3.46M 10-Q · filed 2025-11-03 | $4.42M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $1.10M 10-Q · filed 2025-08-04 | $2.19M 10-Q · filed 2025-08-04 | $3.15M derived: sum of 3 quarters · filed 2026-02-26 | $4.05M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | $1.09M 10-Q · filed 2025-05-05 | $2.05M derived: sum of 2 quarters · filed 2026-02-26 | $2.95M derived: sum of 3 quarters · filed 2026-02-26 | $3.74M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $953.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.85M derived: sum of 2 quarters · filed 2026-02-26 | $2.65M derived: sum of 3 quarters · filed 2026-02-26 | $3.32M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $902.00K 10-Q · filed 2024-11-04 | $1.69M derived: sum of 2 quarters · filed 2024-11-04 | $2.36M 10-Q · filed 2024-11-04 | $2.99M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | $792.00K 10-Q · filed 2024-08-05 | $1.46M 10-Q · filed 2024-08-05 | $2.09M derived: sum of 3 quarters · filed 2025-02-27 | $2.71M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | $670.00K 10-Q · filed 2024-05-02 | $1.30M derived: sum of 2 quarters · filed 2025-02-27 | $1.91M derived: sum of 3 quarters · filed 2025-02-27 | $2.44M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $627.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.24M derived: sum of 2 quarters · filed 2025-02-27 | $1.77M derived: sum of 3 quarters · filed 2025-02-27 | $2.28M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $617.00K 10-Q · filed 2023-11-02 | $1.15M derived: sum of 2 quarters · filed 2023-11-02 | $1.65M 10-Q · filed 2023-11-02 | $2.09M derived: sum of 4 quarters · filed 2023-11-02 | |||
| 2022-06-30 | $531.00K 10-Q · filed 2023-08-02 | $1.03M 10-Q · filed 2023-08-02 | $1.48M derived: sum of 3 quarters · filed 2023-08-02 | $1.87M derived: sum of 4 quarters · filed 2023-08-02 | |||
| 2022-03-31 | $503.00K 10-Q · filed 2023-05-03 | $945.00K derived: sum of 2 quarters · filed 2023-05-03 | $1.34M derived: sum of 3 quarters · filed 2023-05-03 | $1.72M derived: sum of 4 quarters · filed 2023-05-03 | |||
| 2021-12-31 | $442.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $837.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.22M derived: sum of 3 quarters · filed 2023-02-28 | $1.45M 10-K · filed 2023-02-28 | |||
| 2021-09-30 | $395.00K 10-Q · filed 2022-11-02 | $773.00K derived: sum of 2 quarters · filed 2022-11-02 | $1.01M 10-Q · filed 2022-11-02 | $1.17M derived: sum of 4 quarters · filed 2022-11-02 | |||
| 2021-06-30 | $378.00K 10-Q · filed 2022-08-08 | $611.00K 10-Q · filed 2022-08-08 | $771.00K derived: sum of 3 quarters · filed 2022-08-08 | $890.00K derived: sum of 4 quarters · filed 2022-08-08 | |||
| 2021-03-31 | $233.00K 10-Q · filed 2022-05-09 | $393.00K derived: sum of 2 quarters · filed 2022-05-09 | $512.00K derived: sum of 3 quarters · filed 2022-05-09 | $614.00K derived: sum of 4 quarters · filed 2022-05-09 | |||
| 2020-12-31 | $160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $279.00K derived: sum of 2 quarters · filed 2022-02-28 | $381.00K derived: sum of 3 quarters · filed 2022-02-28 | $472.00K 10-K · filed 2022-02-28 | |||
| 2020-09-30 | $119.00K 10-Q · filed 2021-11-08 | $221.00K derived: sum of 2 quarters · filed 2021-11-08 | $312.00K 10-Q · filed 2021-11-08 | $412.00K derived: sum of 4 quarters · filed 2021-11-08 | |||
| 2020-06-30 | $102.00K 10-Q · filed 2021-08-09 | $193.00K 10-Q · filed 2021-08-09 | $293.00K derived: sum of 3 quarters · filed 2021-08-09 | $384.00K derived: sum of 4 quarters · filed 2021-08-09 | |||
| 2020-03-31 | $91.00K 10-Q · filed 2021-05-10 | $191.00K derived: sum of 2 quarters · filed 2021-05-10 | $282.00K derived: sum of 3 quarters · filed 2021-05-10 | $368.00K derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2019-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $191.00K derived: sum of 2 quarters · filed 2021-03-11 | $277.00K derived: sum of 3 quarters · filed 2021-03-11 | $354.00K 10-K · filed 2021-03-11 | |||
| 2019-09-30 | $91.00K 10-Q · filed 2020-11-09 | $91.03K 10-Q · filed 2019-11-12 | $177.00K derived: sum of 2 quarters · filed 2020-11-09 | $254.00K 10-Q · filed 2020-11-09 | $254.31K 10-Q · filed 2019-11-12 | $324.99K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $86.00K 10-Q · filed 2020-08-10 | $85.86K 10-Q · filed 2019-09-03 | $163.00K 10-Q · filed 2020-08-10 | $163.28K 10-Q · filed 2019-09-03 | $233.99K derived: sum of 3 quarters · filed 2020-08-10 | $308.50K derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $77.00K 10-Q · filed 2020-05-11 | $147.99K derived: sum of 2 quarters · filed 2020-05-11 | $222.50K derived: sum of 3 quarters · filed 2020-05-11 | $293.59K derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $70.99K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $145.50K derived: sum of 2 quarters · filed 2020-03-10 | $216.59K derived: sum of 3 quarters · filed 2020-03-10 | $287.00K 10-K · filed 2020-03-10 | |||
| 2018-09-30 | $74.52K 10-Q · filed 2019-11-12 | $145.60K derived: sum of 2 quarters · filed 2019-11-12 | $216.01K 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $71.08K 10-Q · filed 2019-09-03 | $141.50K 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |